(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.83%134.6B | 9.99%99.65B | 12.30%65.2B | 9.62%31.14B | -0.66%123.68B | -0.88%90.6B | -2.40%58.06B | 0.98%28.41B | 16.27%124.49B | 19.00%91.41B |
Operating income | 8.83%134.6B | 9.99%99.65B | 12.30%65.2B | 9.62%31.14B | -0.66%123.68B | -0.88%90.6B | -2.40%58.06B | 0.98%28.41B | 16.27%124.49B | 19.00%91.41B |
Cost of sales | -1.71%-65.03B | -1.33%-47.61B | -1.96%-31.32B | 2.53%-15.15B | 0.59%-63.94B | 0.07%-46.99B | 0.59%-30.72B | -3.63%-15.55B | -16.60%-64.31B | -15.72%-47.03B |
Operating expenses | -1.71%-65.03B | -1.33%-47.61B | -1.96%-31.32B | 2.53%-15.15B | 0.59%-63.94B | 0.07%-46.99B | 0.59%-30.72B | -3.63%-15.55B | -16.60%-64.31B | -15.72%-47.03B |
Gross profit | 16.45%69.57B | 19.32%52.03B | 23.92%33.88B | 24.31%15.99B | -0.73%59.74B | -1.74%43.61B | -4.35%27.34B | -2.03%12.87B | 15.92%60.18B | 22.68%44.38B |
Selling expenses | -14.65%-23.52B | -20.72%-17.67B | -25.92%-11.89B | -20.04%-5.59B | 17.02%-20.51B | 19.92%-14.63B | 13.81%-9.44B | 11.23%-4.66B | -36.87%-24.72B | -40.89%-18.27B |
Research and development expenses | -3.76%-24.19B | -1.40%-17.91B | 0.81%-11.8B | 3.30%-5.42B | 6.51%-23.32B | -0.62%-17.66B | -4.56%-11.9B | -10.00%-5.61B | -27.80%-24.94B | -26.76%-17.55B |
Operating profit | 37.36%21.86B | 45.47%16.46B | 69.81%10.19B | 91.46%4.98B | 51.27%15.91B | 32.22%11.32B | -4.01%6B | -6.74%2.6B | -26.65%10.52B | -8.58%8.56B |
Financing income | 28.25%8.01B | 29.30%5.95B | 29.67%3.86B | 31.71%1.92B | 12.50%6.25B | 13.90%4.6B | 15.69%2.98B | 17.92%1.45B | 3.60%5.55B | -0.32%4.04B |
Financing cost | -11.50%-3.25B | -13.75%-2.47B | -11.72%-1.62B | -13.24%-804M | 14.85%-2.91B | 14.64%-2.18B | 13.01%-1.45B | 13.73%-710M | -10.25%-3.42B | -9.54%-2.55B |
Special items of earning before tax | 84.46%-1.42B | 123.97%2.4B | 139.70%1.72B | 140.05%1.48B | -388.29%-9.13B | -511.43%-10B | -121.22%-4.34B | -115.86%-3.71B | -128.79%-1.87B | -125.20%-1.64B |
Earning before tax | 149.19%25.2B | 497.46%22.33B | 343.56%14.15B | 2,204.17%7.58B | -6.18%10.11B | -55.57%3.74B | -88.44%3.19B | -101.36%-360M | -53.32%10.78B | -52.14%8.41B |
Tax | -41.54%-3.65B | -182.85%-3.75B | -492.07%-2.46B | -205.12%-1.19B | 19.11%-2.58B | 30.02%-1.32B | 88.85%-416M | 74.51%-391M | 21.58%-3.19B | 37.72%-1.89B |
After-tax profit from continuing operations | 186.02%21.55B | 670.01%18.59B | 321.30%11.69B | 949.80%6.38B | -0.75%7.53B | -62.98%2.41B | -88.37%2.78B | -103.00%-751M | -60.10%7.59B | -55.16%6.52B |
Earning after tax | 186.02%21.55B | 670.01%18.59B | 321.30%11.69B | 949.80%6.38B | -0.75%7.53B | -62.98%2.41B | -88.37%2.78B | -103.00%-751M | -60.10%7.59B | -55.16%6.52B |
Minority profit | 5,036.00%1.23B | 554.17%872M | 2,752.17%656M | 315.67%557M | 99.05%-25M | 90.35%-192M | 101.91%23M | 121.58%134M | 23.53%-2.64B | 27.79%-1.99B |
Profit attributable to shareholders | 168.75%20.32B | 579.82%17.72B | 300.98%11.04B | 758.19%5.83B | -26.08%7.56B | -69.38%2.61B | -89.02%2.75B | -103.45%-885M | -54.49%10.23B | -50.80%8.51B |
Basic earnings per share | 179.20%6.98 | 666.25%6.13 | 319.78%3.82 | 661.11%2.02 | -30.17%2.5 | -74.36%0.8 | -90.04%0.91 | -103.79%-0.36 | -56.29%3.58 | -50.71%3.12 |
Diluted earnings per share | 177.82%6.89 | 674.36%6.04 | 322.47%3.76 | 652.78%1.99 | -29.34%2.48 | -72.92%0.78 | -90.00%0.89 | -103.90%-0.36 | -56.77%3.51 | -53.99%2.88 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data
No Data